头颈肿瘤防治的新靶点环氧酶的研究进展
被引量：4
Cylooxgenase-2:a novel molecular target for the prevention and treatment of head and neck cancer on the advance of basic and preclinical research
出处
《中华口腔医学杂志》
CAS
CSCD
北大核心
2004年第3期261-263,共3页
Chinese Journal of Stomatology
基金
上海市科委课题基金资助项目 (0 3JC14 0 5 2 )
参考文献11
-
1Sudbo J, Reith A. Which putatively pre-malignant oral lesions become oral cancers?Clinical relevance of early targeting of high-risk individuals. J Oral Pathol Med, 2003,32:63-70.
-
2Dannenberg AJ, Altorki NK, Boyle JO, et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol, 2001,2:544-551.
-
3Milas L, Mason KA, Liao ZX, et al. Chemoradiotherapy: emerging treatment improvement strategies. Head Neck ,2003,25:152-167.
-
4Lin DT, Subbaramaiah K, Shah JP, et al. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck, 2002,24:792-799.
-
5Zeng Q, McCauley LK, Wang CY.Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2.Implication in head and neck squamous cell carcinoma progression. J Biol Chem, 2002,277:50137-50142.
-
6Dempke W, Rie C, Grothey A, et al. Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol ,2001,127:411-417.
-
7Sudbo J,Ristimaki A, Sondresen JE, et al. Cyclooxgenase-2 (COX-2) expression in high-risk premalignant oral lesions. Oral Oncol, 2003,39:497-505.
-
8Wang Z, Fuentes CF, Shapshay SM. Antiangiogenic and chemopreventive activities of celecoxib in oral carcinoma cell. Laryngoscope, 2002,112:839-843.
-
9Minter HA,Eveson JW,Huntley S, et al. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Clin Cancer Res, 2003,9:1885-1897.
-
10Shiotani H, Denda A ,Yamamoto K, et al. Increased expression of cyclooxygenase-2 protein and 4 nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide. Cancer Res, 2001,61:1451-1456.
同被引文献33
-
1任国欣,郭伟.环氧酶-2在人舌鳞癌及癌前病变组织中的表达[J].口腔颌面外科杂志,2004,14(2):100-103. 被引量：12
-
2石晶,陈谦明.环氧化酶2抑制剂:预防与治疗口腔黏膜癌变的新途径[J].中华口腔医学杂志,2005,40(3):262-264. 被引量：4
-
3张岭漪,王祥,张有成,傅生军,马力.选择性环氧酶-2抑制剂NS-398对肝癌细胞周期和增殖的影响[J].中华肝脏病杂志,2005,13(7):547-548. 被引量：4
-
4金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
-
5Kang KB Wang TT Woon CT Cheah ES Moore XL Zhu C Wong MC.Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib： inhibition of tumor angiogenesis with extensive tumor necrosis[J].中国神经肿瘤杂志,2007,5(2):89-89. 被引量：8
-
6Kyzas PA, Stefanou D, Agnantis NJ. COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol, 2005, 18 ( 1 ) : 153-160.
-
7Soumaoro LT, Uetake H, Takagi Y, et al. Coexpression of VEGF-C and COX-2 in human colorectal cancer and its association with lymph node metastasis. Dis Colon Rectum, 2006, 49 ( 3 ) : 392-398.
-
8Choe MS, Chen Z, Klass CM, et al. Enhancement of docetaxel- induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck. Clin Cancer Res, 2007, 13 (10) :3015-3023.
-
9Hashitani S, Urade M, Nishimura N, et al. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Int J Oncol, 2003, 23(3) :665-672.
-
10Mizutani Y, Nakanishi H, Li YN, et al. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitorJTE-522. J Urol, 2004, 172(4 Pt 1 ) : 1474-1479.
引证文献4
-
1高秀清.环氧酶-2抑制剂的临床应用及研究进展评价[J].中国医院用药评价与分析,2007,7(1):20-22. 被引量：5
-
2李伟忠,王晓燕,李祖国,张进华,丁彦青.塞来昔布增强博来霉素对人舌鳞状细胞癌Tca8113杀伤作用的研究[J].中华口腔医学杂志,2009,44(3):140-143. 被引量：7
-
3霍秋菊,李伟忠.塞来昔布对Tca8113细胞侵袭性影响的体外研究[J].口腔颌面外科杂志,2010,20(1):16-19.
-
4刘春临.塞来昔布对人舌鳞癌Tca-8113细胞表达乙酰肝素酶的影响[J].山西医科大学学报,2012,43(3):195-197. 被引量：1
二级引证文献13
-
1霍秋菊,李伟忠.塞来昔布对Tca8113细胞侵袭性影响的体外研究[J].口腔颌面外科杂志,2010,20(1):16-19.
-
2李伟忠,王小燕,丁彦青.塞来昔布抑制人舌鳞癌Tca8113细胞周期进程及诱导凋亡的作用[J].南方医科大学学报,2010,30(3):486-489. 被引量：2
-
3李伟忠,王晓燕,霍秋菊.塞来昔布对人舌鳞癌Tca8113细胞survivin表达与诱导细胞凋亡的作用[J].广东医学,2010,31(5):543-545. 被引量：2
-
4李伟忠,王晓燕,李祖国,丁彦青.塞来昔布联合顺铂对人舌鳞癌Tca8113细胞移植瘤的生长抑制作用[J].中华肿瘤防治杂志,2010,17(8):579-583. 被引量：3
-
5李伟忠,霍秋菊,王晓燕.环氧化酶-2抑制剂对舌癌细胞侵袭及基质金属蛋白酶-2表达的影响[J].华西口腔医学杂志,2010,28(6):591-594.
-
6李伟忠,王晓燕,霍秋菊.环氧合酶-2抑制剂对人舌鳞癌Tca8113/BLM细胞MDR1/P-gp表达的影响[J].肿瘤防治研究,2011,38(1):9-12. 被引量：1
-
7肖细林,陈卫国,高劲松,游浩,李桂珍,蒋继宏,扈凤平.松生拟层孔菌提取物对肝癌细胞H22和肉瘤细胞S180的抑制作用[J].中国肿瘤生物治疗杂志,2011,18(2):181-185. 被引量：2
-
8郭兴辉,黄永丽,王倩雯,郑子栋.淋洗液在线发生-离子色谱法测定塞来昔布中三氟乙酸残留[J].药物分析杂志,2014,34(6):1077-1079. 被引量：10
-
9王雪,司丽君,刘燕,黄华.天山堇菜总黄酮抗炎和免疫调节作用研究[J].中药药理与临床,2021,37(2):49-54. 被引量：9
-
10司丽君,王雪,王林林,黄华.槲皮素的抗炎免疫及部分机制研究[J].中国医药导报,2021,18(27):26-29. 被引量：102
-
1马玲娣,董燕芬,刘乾,范静,蒋丽佳,陈亚红.三阴性乳腺癌中COX-2、NF-κB及VEGF表达的临床研究[J].国际检验医学杂志,2016,37(4):436-437. 被引量：2
-
2梅俏,于皆平.非甾体类抗炎药与大肠癌化学预防[J].中国药理学通报,2001,17(5):499-502. 被引量：8
-
3郑建涛,陈辉,周俊峰,张琳.直肠巨大绒毛状腺瘤患者环氧酶-2、p53的表达及临床意义[J].中国老年学杂志,2016,36(22):5608-5610. 被引量：1
-
4贾志勇,王家宏,王莹,赵艳飞.环氧合酶-2与肿瘤关系的研究进展[J].包头医学院学报,2009,25(4):104-106. 被引量：2
-
5赵树靓,房静远.大肠癌防治的分子靶点进展[J].中华消化内镜杂志,2008,25(6):333-334.
-
6罗京伟,徐国镇,屠规益.放疗在头颈部癌临床治疗中的作用[J].中华耳鼻咽喉头颈外科杂志,2005,40(11):877-880. 被引量：16
-
7高毅,胡国瑛.头颈肿瘤患者骨显像结果分析[J].现代肿瘤医学,1995,3(4):223-224.
-
8姜战胜,潘战宇,兰岚,谢广茹.表皮生长因子受体单抗治疗头颈部鳞状细胞癌的进展[J].中华耳鼻咽喉头颈外科杂志,2010,45(10):872-874.
-
9李汾,刘东刚.环氧酶2(cyclooxygenase-2)与癌症[J].现代肿瘤医学,2004,12(2):168-169. 被引量：4
-
10ZHOU Qiao-zhi,LIU Hai-bo,DING Xin-chun,LI Peng,ZHANG Shu-tian,YU Zhong-lin.Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway[J].Chinese Medical Journal,2007(23):2086-2091. 被引量：9
